Qualcomm bets on “personal AI” for ears and hospitals

Seventy percent of users say they want AI built into their wearables. That figure, cited by Qualcomm's own Ziad Asghar at the Snapdragon Summit in Hawaii, is the kind of statistic that sounds compelling in a keynote and demands scrutiny everywhere else. But it frames the company's broader ambition clearly: Qualcomm wants AI to live in your ears, not on your screen.

At the summit, Qualcomm introduced 'personal AI' as a formal product category — AI agents that guide users throughout the day via earbuds, glasses, and wearables. Two announcements underpin this push: the Snapdragon Sound Elite Gen 2 chip and a newly formed Personal AI Health Alliance, whose founding members include Optum Health, Scripps Health, Merck KGaA, the Digital Medicine Society, and Biocom.

How does it work?

The Sound Elite Gen 2 is the hardware foundation. Its most significant feature is not audio quality — it is connectivity. The chip carries an integrated micro-power Wi-Fi 6E radio, which allows wearables to communicate directly with cloud services without routing through a smartphone. That single design decision changes what earbuds can do independently.

Qualcomm is also building a software layer around the chip called Snapdragon Sound Apps and Agents, which includes AI assistants, real-time translation, and transcription tools. The company claims the chip delivers double the AI computing power of its predecessor at 128 GOPS, with up to 40 percent lower power consumption and a 30 percent smaller physical footprint. One caveat worth flagging: the power consumption figures are based on simulations and have not yet been validated on final silicon.

The chip also supports earbuds equipped with cameras. Qualcomm's framing — that these cameras 'collect context rather than take photos' — is a careful distinction, and one that regulators in Europe and likely the GCC will want tested against real use cases. Cleer has already shown an early concept combining audio, camera, and AI. Reference designs are expected to help other manufacturers move faster to market.

Why does it matter?

The Personal AI Health Alliance is where the clinical ambition becomes visible. The stated goal is to deploy AI wearables that monitor patients continuously between doctor visits, using on-device processing to keep data local and address privacy concerns. The alliance wants to accelerate both market entry and clinical trials for these devices.

For health systems across the GCC, this direction is worth watching. Saudi Arabia's Vision 2030 health strategy and the UAE's broader digital health agenda both prioritize remote monitoring, early intervention, and reducing pressure on acute care facilities. Continuous, AI-driven monitoring between appointments fits that framework directly. Still, the alliance has not announced concrete products or published clinical results. What exists now is a commitment to proofs of concept, accessible through PAIHealth.org.

The context

Qualcomm is looking for a third major growth market after PCs and smartphones. The screenless AI narrative it is now building around earbuds and wearables is one that earlier AI gadgets — most notably the Humane AI Pin — failed to establish commercially. Qualcomm's approach is different in that it is embedding the capability into a chip that device makers already know, rather than asking consumers to adopt an entirely new form factor.

The healthcare alliance adds institutional credibility, but also raises the bar. Clinical validation takes time. Regulatory pathways for AI-enabled medical wearables are still being written in most jurisdictions, including those across the Gulf. The foundations Qualcomm is laying are real. Whether hospitals, insurers, and patients decide to build on them is the question that the next few years will answer.